Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P H de Mulder

Showing results (41-50 of 137) with videos related to

Pageof 14
Sort By:
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Phase II trial of cisplatin for adenocarcinoma of unknown primary site. IKZ/IKO Clinical Research GroupD J Wagener, P H de Mulder, J T Burghouts, et al.
Nederlands Tijdschrift Voor Geneeskunde|June 1, 1991
[Peritoneovenous shunt in the treatment of ascites caused by a malignancy]R C Rietbroek, P H de Mulder, Q G van Hoesel, et al.
Nederlands Tijdschrift Voor Geneeskunde|August 19, 1989
[The central venous catheter in the treatment of patients with malignancies]R J van Klaveren, P H de Mulder, T Wobbes, et al.
Breast Cancer Research and Treatment|January 1, 1993
Long-term follow up of breast cancer patients treated for hypercalcaemia with aminohydroxypropylidene bisphosphate (APD)J C Grutters, A R Hermus, P H de Mulder, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1992
Alpha-interferon in combination with 5-fluorouracil and leucovorin in metastatic colorectal cancer: a phase I studyC J Punt, P H de Mulder, J T Burghouts, et al.
Seminars in Oncology|February 1, 1994
The application of hematopoietic growth factors in advanced transitional cell carcinoma of the urinary tractP H de Mulder, C N Sternberg, A T van Oosterom, et al.
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy|July 1, 1992
Human leukocyte antigen expression in renal cell carcinoma lesions does not predict the response to interferon therapyV Mattijssen, J Van Moorselaar, P H De Mulder, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 1, 1997
Treatment in germ cell tumours: state of the artV C Tjan-Heijnen, G O Oosterhof, R de Wit, et al.
Oncology|November 1, 1996
Experimental and clinical efficacy of 2', 2'-difluorodeoxycytidine (gemcitabine) against renal cell carcinomaD Rohde, P H De Mulder, L Weissbach, et al.
British Journal of Cancer|March 28, 2007
Carbonic anhydrase IX expression is more predictive than prognostic in breast cancerP N Span, J Bussink, P H De Mulder, et al.
Pageof 14

Showing results (41-50 of 137) with videos related to

Sort By:
Pageof 14
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Phase II trial of cisplatin for adenocarcinoma of unknown primary site. IKZ/IKO Clinical Research GroupD J Wagener, P H de Mulder, J T Burghouts, et al.
Nederlands Tijdschrift Voor Geneeskunde|June 1, 1991
[Peritoneovenous shunt in the treatment of ascites caused by a malignancy]R C Rietbroek, P H de Mulder, Q G van Hoesel, et al.
Nederlands Tijdschrift Voor Geneeskunde|August 19, 1989
[The central venous catheter in the treatment of patients with malignancies]R J van Klaveren, P H de Mulder, T Wobbes, et al.
Breast Cancer Research and Treatment|January 1, 1993
Long-term follow up of breast cancer patients treated for hypercalcaemia with aminohydroxypropylidene bisphosphate (APD)J C Grutters, A R Hermus, P H de Mulder, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1992
Alpha-interferon in combination with 5-fluorouracil and leucovorin in metastatic colorectal cancer: a phase I studyC J Punt, P H de Mulder, J T Burghouts, et al.
Seminars in Oncology|February 1, 1994
The application of hematopoietic growth factors in advanced transitional cell carcinoma of the urinary tractP H de Mulder, C N Sternberg, A T van Oosterom, et al.
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy|July 1, 1992
Human leukocyte antigen expression in renal cell carcinoma lesions does not predict the response to interferon therapyV Mattijssen, J Van Moorselaar, P H De Mulder, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 1, 1997
Treatment in germ cell tumours: state of the artV C Tjan-Heijnen, G O Oosterhof, R de Wit, et al.
Oncology|November 1, 1996
Experimental and clinical efficacy of 2', 2'-difluorodeoxycytidine (gemcitabine) against renal cell carcinomaD Rohde, P H De Mulder, L Weissbach, et al.
British Journal of Cancer|March 28, 2007
Carbonic anhydrase IX expression is more predictive than prognostic in breast cancerP N Span, J Bussink, P H De Mulder, et al.
Pageof 14